FO
FT Options Portfolio holdings
AUM
$40M
This Quarter Return
-3.32%
1 Year Return
+13.03%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$68M
AUM Growth
+$68M
(-16%)
Cap. Flow
-$10.5M
Cap. Flow
% of AUM
-15.5%
Top 10 Holdings %
Top 10 Hldgs %
55.84%
Holding
220
New
38
Increased
14
Reduced
19
Closed
48
Top Buys
| 1 |
JPMorgan Chase
JPM
|
$3.58M |
| 2 |
Constellation Brands
STZ
|
$3.07M |
| 3 |
General Mills
GIS
|
$2.28M |
| 4 |
Gilead Sciences
GILD
|
$2.21M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$2M |
Top Sells
| 1 |
Procter & Gamble
PG
|
$4.04M |
| 2 |
Bristol-Myers Squibb
BMY
|
$3.97M |
| 3 |
CASC
Cascadian Therapeutics, Inc.
CASC
|
$3.19M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$2.56M |
| 5 |
iShares Biotechnology ETF
IBB
|
$2.03M |
Sector Composition
| 1 | Healthcare | 57.22% |
| 2 | Consumer Staples | 17.99% |
| 3 | Consumer Discretionary | 5.6% |
| 4 | Financials | 5.26% |
| 5 | Communication Services | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSRO
51
DELISTED
TESARO, Inc.
TSRO
| $253K | 0.29% |
1,880
-2,165
| -54% | -$291K |
|
52
Yelp
YELP
$1.99B
| $252K | 0.29% |
6,596
+5,996
| +999% | +$229K |
|
53
Coca-Cola Europacific Partners
CCEP
$40.4B
| $251K | 0.29% |
+8,000
| New | +$251K |
|
54
Alnylam Pharmaceuticals
ALNY
$58.5B
| $244K | 0.28% |
+6,526
| New | +$244K |
|
55
Coca-Cola
KO
$297B
| $231K | 0.27% |
5,561
-9,400
| -63% | -$390K |
|
56
Campbell Soup
CPB
$9.38B
| $180K | 0.21% |
+2,983
| New | +$180K |
|
|
SVVC
57
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
| $171K | 0.2% |
22,238
| – | – |
|
|
DNKN
58
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $128K | 0.15% |
+2,450
| New | +$128K |
|
59
Mattel
MAT
$5.9B
| $124K | 0.14% |
+4,500
| New | +$124K |
|
|
NIHD
60
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| $118K | 0.14% |
55,000
| – | – |
|
61
Planet Fitness
PLNT
$8.79B
| $104K | 0.12% |
+5,161
| New | +$104K |
|
62
Qualcomm
QCOM
$171B
| $84K | 0.1% |
+1,287
| New | +$84K |
|
63
Salesforce
CRM
$242B
| $82K | 0.09% |
1,200
-2,400
| -67% | -$164K |
|
64
Cigna
CI
$80.3B
| $80K | 0.09% |
+600
| New | +$80K |
|
|
ALPN
65
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $78K | 0.09% |
+35,000
| New | +$78K |
|
66
Bausch Health
BHC
$2.74B
| $75K | 0.09% |
+5,182
| New | +$75K |
|
67
Astria Therapeutics
ATXS
$349M
| $64K | 0.07% |
17,736
| – | – |
|
68
Dynavax Technologies
DVAX
$1.19B
| $62K | 0.07% |
15,581
-11,449
| -42% | -$45.6K |
|
69
Amicus Therapeutics
FOLD
$2.34B
| $44K | 0.05% |
+8,792
| New | +$44K |
|
70
Alaunos Therapeutics
TCRT
$4.21M
| $44K | 0.05% |
8,143
-11,857
| -59% | -$64.1K |
|
|
ICPT
71
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $43K | 0.05% |
+400
| New | +$43K |
|
72
Macy's
M
$3.66B
| $36K | 0.04% |
1,000
-6,500
| -87% | -$234K |
|
73
MannKind Corp
MNKD
$1.76B
| $21K | 0.02% |
+33,300
| New | +$21K |
|
|
ALR
74
DELISTED
Alere Inc
ALR
| $19K | 0.02% |
+500
| New | +$19K |
|
|
LUMO
75
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $10K | 0.01% |
1,003
+1,000
| +33,333% | +$9.97K |
|